Home - Products - Angiogenesis - CDK - Eciruciclib

Eciruciclib

CAS No. 1868086-40-1

Eciruciclib( —— )

Catalog No. M28496 CAS No. 1868086-40-1

Eciruciclib is an inhibitor of CDK with antitumor properties.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
5MG	312	Get Quote
10MG	500	Get Quote
25MG	807	Get Quote
50MG	1107	Get Quote
100MG	1485	Get Quote
200MG	Get Quote	Get Quote
500MG	Get Quote	Get Quote
1G	Get Quote	Get Quote

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Eciruciclib
Note

Research use only, not for human use.
Brief Description

Eciruciclib is an inhibitor of CDK with antitumor properties.
Description

Eciruciclib is an inhibitor of CDK with antitumor properties.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

Angiogenesis
Target

CDK
Recptor

——
Research Area

——
Indication

——

Chemical Information

CAS Number

1868086-40-1
Formula Weight

488.6
Molecular Formula

C27H33FN8
Purity

>98% (HPLC)
Solubility

In Vitro:?DMSO : 2 mg/mL (4.09 mM)
SMILES

CC(C1=C2C=C(C3=NC(NC4=NC=C(CN5CCN(CC)CC5)C=C4)=NC=C3F)C=CC2=NN1C)C
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

THZ1 2HCl

THZ1 2HCl is a selective, covalent, and allosteric inhibitor of CDK7 with an IC50 of 3.2 nM. THZ1 2HCl has antiproliferative effects on a variety of cancer cell lines.
JNJ-7706621

A dual CDK/Aurora kinase inhibitor with IC50 of 9/4/11/15 nM for CDK1/CDK2/Aurora A/Aurora B respectively; also exhibits activity towards CDK3, CDK4, and CDK6 (IC50s=50-250 nM).
Indirubin-3-monoxime

Indirubin-3-monoxime is an effective inhibitor of cyclin-dependent protein kinases, and may play an obligate role in neuronal apoptosis in Alzheimer's disease.

Sign In Join Free